These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 11738300)

  • 41. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute echocardiographic optimization of multiple stimulation configurations of cardiac resynchronization therapy through quadripolar left ventricular pacing: a tailored approach.
    Calò L; Martino A; de Ruvo E; Minati M; Fratini S; Rebecchi M; Lanzillo C; Fagagnini A; Borrelli A; De Luca L; Sciarra L
    Am Heart J; 2014 Apr; 167(4):546-54. PubMed ID: 24655704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy.
    Shanks M; Delgado V; Ng AC; Auger D; Mooyaart EA; Bertini M; Marsan NA; van Bommel RJ; Holman ER; Poldermans D; Schalij MJ; Bax JJ
    Am Heart J; 2011 Mar; 161(3):552-7. PubMed ID: 21392611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?
    Abdelhamid MA; Ghanem MT; Abdelmotaleb AM
    Indian Heart J; 2017; 69(6):731-735. PubMed ID: 29174250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence, predictors, and impact on outcome of increased left ventricular latency in patients undergoing cardiac resynchronization therapy.
    D'Onofrio A; Caico SI; Iuliano A; Pieragnoli P; Bianchi V; Orsida D; Pani A; Pasqualini M; Amadori F; Vasquez L; Talarico A; Minoia C; Ospizio R; Merlotti G; Malacrida M; Stabile G
    J Interv Card Electrophysiol; 2018 Apr; 51(3):245-252. PubMed ID: 29502194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application and efficacy of the adjustment on left ventricular electrical delay and the distance between right and left ventricular pacing polar in optimizing the left ventricular pacing polar].
    Yan XL; Liang YC; Yu HB; Xu BG; Gao Y; Liu R; Xu GQ; Wu M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):669-674. PubMed ID: 32847323
    [No Abstract]   [Full Text] [Related]  

  • 51. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing.
    Bernheim A; Ammann P; Sticherling C; Burger P; Schaer B; Brunner-La Rocca HP; Eckstein J; Kiencke S; Kaiser C; Linka A; Buser P; Pfisterer M; Osswald S
    J Am Coll Cardiol; 2005 May; 45(9):1482-7. PubMed ID: 15862423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure.
    Waggoner AD; Rovner A; de las Fuentes L; Faddis MN; Gleva MJ; Sawhney N; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Mar; 19(3):307-13. PubMed ID: 16500494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are changes in the extent of left ventricular dyssynchrony as assessed by speckle tracking associated with response to cardiac resynchronization therapy?
    Ghani A; Delnoy PP; Ottervanger JP; Ramdat Misier AR; Smit JJ; Adiyaman A; Elvan A
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):553-61. PubMed ID: 26585749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
    Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy.
    Soliman OI; Geleijnse ML; Theuns DA; van Dalen BM; Vletter WB; Jordaens LJ; Metawei AK; Al-Amin AM; ten Cate FJ
    Am J Cardiol; 2009 Jun; 103(11):1586-91. PubMed ID: 19463520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure?
    Sack S; Franz R; Dagres N; Oldenburg O; Herrmann J; Golles A; Erbel R
    Am J Cardiol; 1999 Mar; 83(5B):124D-129D. PubMed ID: 10089854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.